Torrent Pharmaceuticals Limited (TORNTPHARM) — Announcement | 11 August 2026(2 announcements)
Torrent Pharmaceuticals announced its participation in an investors' meet hosted by Emkay on August 14, 2026, in Mumbai, as part of Regulation 30 compliance for SEBI disclosure obligations. The filing confirms scheduled one-on-one and group meetings with institutional investors, subject to change based on company or investor exigencies.
Torrent Pharmaceuticals announced that NSE Sustainability Ratings and Analytics assigned the company an ESG rating of 70, reflecting its environmental, social, and governance performance. This rating highlights the firm's commitment to sustainable practices and may enhance its appeal to ESG-focused investors.
About Torrent Pharmaceuticals Limited (TORNTPHARM)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when TORNTPHARM files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track TORNTPHARM — Free💡 Ask AI about this filing
📊 More TORNTPHARM filings
- 🔴 Financial Results — 4 August 2026 Torrent Pharmaceuticals announced a conference call transcript for Q1 FY26 results on August 4, 2026...
- 🟡 Board Meeting — 1 August 2026 Torrent Pharmaceuticals announced the cessation of Ameera Shah as an Independent Director effective ...
- 🔴 Financial Results — 30 July 2026 Torrent Pharmaceuticals announced that the audio recording of its conference call discussing financi...
- 🔴 Financial Results — 30 July 2026 Torrent Pharmaceuticals reported record Q1 FY27 revenue of **₹4,921 crores**, up **55% YoY**, driven...
- 🟡 Board Meeting — 30 July 2026 Torrent Pharmaceuticals reported consolidated revenue of **₹4,921 crores** (+55% YoY) and net profit...
🔥 Also filed on 11 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when TORNTPHARM files new disclosures
Track TORNTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track TORNTPHARM — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research